BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23168175)

  • 21. TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract.
    Yang HK; Linnoila RI; Conrad NK; Krasna MJ; Aisner SC; Johnson BE; Kelley MJ
    Int J Cancer; 1995 Aug; 64(4):229-33. PubMed ID: 7657384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.
    Tenti P; Pavanello S; Padovan L; Spinillo A; Vesentini N; Zappatore R; Migliora P; Zara C; Ranzani GN; Carnevali L
    Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic characterization of small cell carcinomas of the uterine cervix.
    Schultheis AM; de Bruijn I; Selenica P; Macedo GS; da Silva EM; Piscuoglio S; Jungbluth AA; Park KJ; Klimstra DS; Wardelmann E; Hartmann W; Gerharz CD; von Petersdorff M; Buettner R; Reis-Filho JS; Weigelt B
    Mol Oncol; 2022 Feb; 16(4):833-845. PubMed ID: 33830625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
    Kandioler D; Schoppmann SF; Zwrtek R; Kappel S; Wolf B; Mittlböck M; Kührer I; Hejna M; Pluschnig U; Ba-Ssalamah A; Wrba F; Zacherl J
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2280-6. PubMed ID: 25135238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in TP53 tumor suppressor gene in wood dust-related sinonasal cancer.
    Holmila R; Bornholdt J; Heikkilä P; Suitiala T; Févotte J; Cyr D; Hansen J; Snellman SM; Dictor M; Steiniche T; Schlünssen V; Schneider T; Pukkala E; Savolainen K; Wolff H; Wallin H; Luce D; Husgafvel-Pursiainen K
    Int J Cancer; 2010 Aug; 127(3):578-88. PubMed ID: 19950227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.
    Anna L; Holmila R; Kovács K; Gyorffy E; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Husgafvel-Pursiainen K; Schoket B
    Mutagenesis; 2009 Nov; 24(6):475-80. PubMed ID: 19643813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
    Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
    Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.
    Kessis TD; Slebos RJ; Han SM; Shah K; Bosch XF; Muñoz N; Hedrick L; Cho KR
    Am J Pathol; 1993 Nov; 143(5):1398-405. PubMed ID: 8238255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV infection and p16
    Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
    Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
    Kang S; Kim JW; Kang GH; Lee S; Park NH; Song YS; Park SY; Kang SB; Lee HP
    Int J Cancer; 2006 May; 118(9):2168-71. PubMed ID: 16331610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China.
    Hu N; Huang J; Emmert-Buck MR; Tang ZZ; Roth MJ; Wang C; Dawsey SM; Li G; Li WJ; Wang QH; Han XY; Ding T; Giffen C; Goldstein AM; Taylor PR
    Clin Cancer Res; 2001 Apr; 7(4):883-91. PubMed ID: 11309337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
    Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
    Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
    Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rearrangement of p53 gene with overexpressed p53 protein in primary cervical cancer.
    Sahu GR; Nayak BK; Patnaik S; Parija T; Das BR
    Oncol Rep; 2002; 9(2):433-7. PubMed ID: 11836622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection.
    Eicheler W; Zips D; Dörfler A; Grénman R; Baumann M
    J Histochem Cytochem; 2002 Feb; 50(2):197-204. PubMed ID: 11799138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
    Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TP53 mutation, allelism and survival in non-small cell lung cancer.
    Nelson HH; Wilkojmen M; Marsit CJ; Kelsey KT
    Carcinogenesis; 2005 Oct; 26(10):1770-3. PubMed ID: 15905205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 gene alterations and human papillomavirus type 16 infection in early stages of cervical carcinoma in Serbia.
    Malisic E; Jankovic R; Majkic M; Dobricic J; Radulovic S
    J BUON; 2008; 13(4):525-32. PubMed ID: 19145674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile of TP53 gene mutations in sinonasal cancer.
    Holmila R; Bornholdt J; Suitiala T; Cyr D; Dictor M; Steiniche T; Wolff H; Wallin H; Luce D; Husgafvel-Pursiainen K
    Mutat Res; 2010 Apr; 686(1-2):9-14. PubMed ID: 20025891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.